Simon Baker
Stock Analyst at Redburn Atlantic
(0.31)
# 4,053
Out of 4,827 analysts
8
Total ratings
25%
Success rate
-12.91%
Average return
Main Sectors:
Stocks Rated by Simon Baker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics | Upgrades: Buy | $13 | $1.35 | +862.96% | 1 | Nov 15, 2024 | |
| BNTX BioNTech SE | Upgrades: Buy | $165 → $170 | $94.78 | +79.36% | 3 | May 17, 2023 | |
| QGEN Qiagen | Initiates: Buy | n/a | $42.16 | - | 1 | Oct 14, 2021 | |
| ABT Abbott Laboratories | Initiates: Neutral | n/a | $134.00 | - | 1 | Oct 14, 2021 | |
| HOLX Hologic | Initiates: Neutral | n/a | $56.18 | - | 1 | Oct 14, 2021 | |
| FOXA Fox Corporation | Upgrades: Hold | $29 → $24 | $50.42 | -52.40% | 1 | Apr 8, 2020 |
Autolus Therapeutics
Nov 15, 2024
Upgrades: Buy
Price Target: $13
Current: $1.35
Upside: +862.96%
BioNTech SE
May 17, 2023
Upgrades: Buy
Price Target: $165 → $170
Current: $94.78
Upside: +79.36%
Qiagen
Oct 14, 2021
Initiates: Buy
Price Target: n/a
Current: $42.16
Upside: -
Abbott Laboratories
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $134.00
Upside: -
Hologic
Oct 14, 2021
Initiates: Neutral
Price Target: n/a
Current: $56.18
Upside: -
Fox Corporation
Apr 8, 2020
Upgrades: Hold
Price Target: $29 → $24
Current: $50.42
Upside: -52.40%